A-Alpha Bio utilizes its AlphaSeq and AlphaBind platforms to generate high-resolution protein-protein interaction data at scale, enabling the discovery and engineering of effective protein therapeutics. The company addresses the challenge of limited high-quality interaction data, which hampers the understanding and treatment of diseases such as cancer and neurological disorders.

Agoprene produces a seaweed‑based bio‑foam that replaces petroleum‑derived polyurethane in furniture padding, cushions, and packaging. The foam is fully compostable in industrial facilities within two months, meets fire safety and durability standards, and is manufactured using over 90 % renewable energy, offering manufacturers a low‑impact, cost‑effective alternative without compromising performance.

The startup offers an automation platform that utilizes 3D vision technology to enable real-time cloud-based recreation of physical environments using low-cost depth and 3D cameras. This platform simplifies the deployment of machine vision systems, making it easier for clients to implement large-scale video camera automation.

Alife provides an AI-powered software platform designed to optimize In Vitro Fertilization (IVF) clinic operations. The platform integrates with EMR systems to deliver actionable insights for embryo grading, patient communication, and lab scheduling. This data-driven approach helps fertility clinics increase efficiency, reduce operating costs, and improve patient satisfaction.

ANB Sensors develops self-calibrating solid-state pH sensors that eliminate the need for manual calibration, significantly reducing operating costs by up to 70%. These sensors are designed for oceanographic and water resource management applications, providing reliable performance without the fragility and maintenance issues associated with traditional glass electrodes.

Augere Medical has developed PolypAid™, an AI-driven video analysis system that enhances polyp detection during colonoscopy by providing real-time feedback on adenomas and sessile serrated lesions. This technology addresses the issue of missed polyps, which can lead to delayed cancer diagnoses, by improving detection rates and potentially reducing the long-term costs of colorectal cancer treatment.

This startup produces biodegradable tampons and pads made from organic cotton, ensuring that menstrual products are accessible to all individuals with periods. By providing free-vend, wall-mounted dispensers, the company enables businesses and schools to offer these essential hygiene products at no cost to employees, students, and guests.

Aura is a digital wellness platform that utilizes machine learning algorithms to deliver personalized mental health content, including meditations, sleep tracks, and therapy sessions, tailored to individual user needs. It addresses issues such as anxiety, stress, and sleep disturbances by providing a vast library of resources and one-on-one coaching from certified professionals, enhancing overall well-being.

Birdsview develops AI algorithms that analyze sensor data to assess the health of critical infrastructure, including wooden and concrete structures. Their technology provides accurate, non-destructive insights into asset integrity, enabling proactive maintenance and extending the lifespan of aging infrastructure.

Blykalla develops the Swedish Advanced Lead Reactor (SEALER), a 55 MW lead‑cooled small modular reactor that provides clean, dispatchable baseload power in a compact 5 × 5 m factory‑produced unit. Its low‑pressure, lead‑coolant system offers passive, walk‑away safety and corrosion‑resistant materials, enabling rapid, modular deployment for utilities and industrial users needing reliable electricity, high‑temperature heat, hydrogen, or desalination capacity.

The startup develops monoclonal antibody treatments utilizing hybridoma technology to induce programmed cell death in cancer cells. This approach enhances treatment options for cancer patients by targeting specific pathways that lead to tumor cell elimination.

This company develops a novel ship class utilizing wind energy for propulsion to transport ocean freight. Their autonomous, smaller vessels enable decentralized, direct point-to-point transport, offering lower operational costs and emission-free shipping. The technology provides individualized service and improved schedule reliability compared to conventional large container vessels.

The startup offers a content licensing platform that enables users to discover and license film, photography, and audio from a diverse range of creators, including artists and hobbyists. This platform streamlines the content curation process for agencies and brands, allowing them to efficiently acquire story-driven media to enhance their marketing efforts.

Cimon Medical develops the NeoDoppler system, a novel Doppler ultrasound technology that provides continuous, non-invasive monitoring of cerebral blood flow. This technology addresses the lack of direct measurement options for brain blood flow, particularly in vulnerable populations such as newborns during transport.

Desert Control develops soil enhancement technology that transforms degraded, sandy soils into fertile land by utilizing a proprietary water retention solution. This technology addresses the challenges of soil degradation and water scarcity, enabling sustainable agricultural practices in arid regions.

Evari develops miniature, oil-free turbocompressors for heat pumps, designed to operate efficiently without polluting refrigerants. Their technology addresses the high energy consumption and emissions associated with traditional heating and cooling systems, contributing to a significant reduction in global CO2 emissions.

Evoy designs and manufactures electric motor systems for boats, offering continuous power options ranging from 120 to 400+ horsepower with minimal moving parts for enhanced reliability. These systems provide a sustainable alternative to traditional combustion engines, significantly reducing emissions and maintenance needs while delivering a quiet boating experience.

Fauna Bio utilizes an AI-driven platform, Convergence™, to analyze genetic data from diverse mammalian species, enabling the discovery of novel therapeutic targets for age-related diseases and metabolic disorders. By replicating the natural disease resistance mechanisms found in these animals, the company aims to develop effective drugs that can improve human health outcomes.

Inherit Carbon Solutions provides a bioenergy with carbon capture and storage (BECCS) service that turns food waste and sewage into biogas, captures the CO₂, and permanently stores it underground for over a thousand years. Their low‑energy, modular facilities are sited near waste streams, eliminating the need for dedicated power or agricultural land, and they issue verified carbon removal credits only after successful sequestration, offering corporations a credible, pay‑on‑delivery path to meet climate targets.

Iris.ai offers an AI science assistant that utilizes large language models to help research and development teams efficiently locate and extract relevant research content from unstructured data. This technology addresses the challenge of navigating vast amounts of scientific literature, enabling faster insights and innovation in various industries.

This startup provides 3D printing analysis and management services to facilitate the digital distribution of spare parts and local on-demand manufacturing. By connecting clients to a network of manufacturers, it enables faster delivery times and reduces uncertainty in inventory management.

The startup has developed a digital platform for cognitive testing that evaluates patients' cognitive states by measuring speed, attention, visuospatial ability, and memory. This platform enables health centers to enhance patient follow-up processes through standardized assessments, improving overall patient care.

Molecular Attraction develops patented bio-attractants that alter the behavior of vector organisms, such as mosquitoes and ticks, to reduce their populations without harming beneficial insects. The company addresses the global challenge of vector-borne diseases by providing environmentally friendly solutions that minimize pesticide use and target specific pest species.

NaDeNo develops a nanotechnology drug delivery platform utilizing biodegradable and biocompatible polymeric nanoparticles to encapsulate hydrophobic small molecule drugs, addressing the challenge of low water solubility that leads to high failure rates in drug development. The platform enables controlled drug release and improved efficacy, facilitating the repurposing of effective drugs for areas with significant unmet medical needs.